GSK Plc (GSK)
53.34
+0.87
(+1.66%)
USD |
NYSE |
Feb 03, 16:00
55.24
+1.90
(+3.56%)
Pre-Market: 05:49
GSK EPS Diluted (Quarterly) : 1.324 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AstraZeneca PLC | 0.8063 |
| Mereo BioPharma Group Plc | -0.0436 |
| Biodexa Pharmaceuticals Plc | -- |
| AnaptysBio, Inc. | 0.5208 |
| NuCana Plc | -0.1348 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.891B |
| Revenue (Quarterly) | 11.53B |
| Total Expenses (Quarterly) | 8.812B |
| Enterprise Value | 126.10B |
| Gross Profit Margin (Quarterly) | 73.80% |
| Profit Margin (Quarterly) | 25.08% |
| Earnings Yield | 6.57% |
| Operating Earnings Yield | 8.98% |
| Normalized Earnings Yield | 7.432 |